Login
Home
Charts
Search
Watchlist
Products

Triochem Products Ltd

TRIPR·BSE
₹17.40+1.75%Thu, 24 Sept '15
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Triochem Products Ltd

TRIPR
BSE
₹17.40
+1.75%
|Thu, 24 Sept '15
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹0Cr
Close
Close Price
₹17.40
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
—
PS
Price To Sales
—
Revenue
Revenue
₹0Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
1,983.72%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000001000000
Operating Profit
Operating ProfitCr
00000-1000000
OPM
OPM%
Other Income
Other IncomeCr
-1010000000110
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-1000000000110
Tax
TaxCr
000000000030
PAT
PATCr
-100000000080
Growth YoY
PAT Growth YoY%
-312.020.0260.027.396.1145.0-240.662.5-375.0-244.41,951.1400.0
NPM
NPM%
EPS
EPS₹
5.3-8.313.2-3.2-1.53.6-18.4-1.3-7.9-5.4-116.03.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000001000000
Operating Profit
Operating ProfitCr
00000-1000000
OPM
OPM%
Other Income
Other IncomeCr
-1010000000110
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-1000000000110
Tax
TaxCr
000000000030
PAT
PATCr
-100000000080
Growth YoY
PAT Growth YoY%
-312.020.0260.027.396.1145.0-240.662.5-375.0-244.41,951.1400.0
NPM
NPM%
EPS
EPS₹
5.3-8.313.2-3.2-1.53.6-18.4-1.3-7.9-5.4-116.03.9

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
231835122014900000
Growth
Revenue Growth%
-24.7-21.993.7-64.762.1-30.4-36.7-100.0
Expenses
ExpensesCr
221731111614711111
Operating Profit
Operating ProfitCr
1142401-1-1-1-1-1
OPM
OPM%
4.15.510.813.322.4-3.415.1
Other Income
Other IncomeCr
00000010011212
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
11415-12-1-101111
Tax
TaxCr
001010000033
PAT
PATCr
0131301-1-1088
Growth
PAT Growth%
-17.968.6343.6-70.9358.0-113.1395.9-166.9-14.560.52,091.21,983.7
NPM
NPM%
1.53.27.36.017.0-3.215.0
EPS
EPS₹
13.923.5104.330.3138.9-18.254.0-36.1-41.4-16.3325.3-125.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
231835122014900000
Growth
Revenue Growth%
-24.7-21.993.7-64.762.1-30.4-36.7-100.0
Expenses
ExpensesCr
221731111614711111
Operating Profit
Operating ProfitCr
1142401-1-1-1-1-1
OPM
OPM%
4.15.510.813.322.4-3.415.1
Other Income
Other IncomeCr
00000010011212
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
11415-12-1-101111
Tax
TaxCr
001010000033
PAT
PATCr
0131301-1-1088
Growth
PAT Growth%
-17.968.6343.6-70.9358.0-113.1395.9-166.9-14.560.52,091.21,983.7
NPM
NPM%
1.53.27.36.017.0-3.215.0
EPS
EPS₹
13.923.5104.330.3138.9-18.254.0-36.1-41.4-16.3325.3-125.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
00000000000
Reserves
ReservesCr
558912111311141320
Current Liabilities
Current LiabilitiesCr
25464000000
Non Current Liabilities
Non Current LiabilitiesCr
00000000000
Total Liabilities
Total LiabilitiesCr
710121517121312151421
Current Assets
Current AssetsCr
18101415111213313
Non Current Assets
Non Current AssetsCr
62211111112118
Total Assets
Total AssetsCr
710121517121312151421
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
00000000000
Reserves
ReservesCr
558912111311141320
Current Liabilities
Current LiabilitiesCr
25464000000
Non Current Liabilities
Non Current LiabilitiesCr
00000000000
Total Liabilities
Total LiabilitiesCr
710121517121312151421
Current Assets
Current AssetsCr
18101415111213313
Non Current Assets
Non Current AssetsCr
62211111112118
Total Assets
Total AssetsCr
710121517121312151421

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7-61-44103-1-40-3
Investing Cash Flow
Investing Cash FlowCr
-4400000-103014
Financing Cash Flow
Financing Cash FlowCr
-43-13-3-300000
Net Cash Flow
Net Cash FlowCr
-101-1084-110011
Free Cash Flow
Free Cash FlowCr
7-71-44103-1-409
CFO To PAT
CFO To PAT%
1,986.6-1,125.356.7-504.3112.3-2,294.1262.2116.2370.7-50.2-36.1
CFO To EBITDA
CFO To EBITDA%
711.7-657.538.2-227.985.3-2,194.9259.876.6337.4-16.5207.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7-61-44103-1-40-3
Investing Cash Flow
Investing Cash FlowCr
-4400000-103014
Financing Cash Flow
Financing Cash FlowCr
-43-13-3-300000
Net Cash Flow
Net Cash FlowCr
-101-1084-110011
Free Cash Flow
Free Cash FlowCr
7-71-44103-1-409
CFO To PAT
CFO To PAT%
1,986.6-1,125.356.7-504.3112.3-2,294.1262.2116.2370.7-50.2-36.1
CFO To EBITDA
CFO To EBITDA%
711.7-657.538.2-227.985.3-2,194.9259.876.6337.4-16.5207.2

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
Price To Book
Price To Book
0.0
EV To EBITDA
EV To EBITDA
Profitability Ratios
Profitability Ratios
GPM
GPM%
8.111.214.322.327.94.222.9
OPM
OPM%
4.15.510.813.322.4-3.415.1
NPM
NPM%
1.53.27.36.017.0-3.215.0
ROCE
ROCE%
14.510.438.410.332.6-4.013.7-10.1-9.1-1.851.351.3
ROE
ROE%
7.010.531.88.527.9-3.810.1-7.6-6.9-2.938.638.6
ROA
ROA%
4.95.621.74.920.5-3.79.9-7.5-6.8-2.938.238.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
Price To Book
Price To Book
0.0
EV To EBITDA
EV To EBITDA
Profitability Ratios
Profitability Ratios
GPM
GPM%
8.111.214.322.327.94.222.9
OPM
OPM%
4.15.510.813.322.4-3.415.1
NPM
NPM%
1.53.27.36.017.0-3.215.0
ROCE
ROCE%
14.510.438.410.332.6-4.013.7-10.1-9.1-1.851.351.3
ROE
ROE%
7.010.531.88.527.9-3.810.1-7.6-6.9-2.938.638.6
ROA
ROA%
4.95.621.74.920.5-3.79.9-7.5-6.8-2.938.238.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Triochem Products Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/wwrtemgl0qbn2p9j2rev514y.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/571wk9k0useny60k26r32nu1.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/52zxhasqczgd1xqkggbqksge.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/8fe7vqyaxizjr5d12w7j8x3k.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/6jxic5uacqhjqsrlji2cmaoi.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/8etv43h9jleawa2yd8dggcfz.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/65ksch283dgjhd4ur5n5l1jo.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/01df4xlcg0gdnfarlnd71w6c.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/uusr27nr0p97d3k96olk5wir.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/ym4dxp07v13yzojx892v2i25.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/gqur3cpqmnbnmo0gz5l2dc5h.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/32x1s0c428udkt8dywt42pex.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/vnsm4smewehe1xo3in6f4gzx.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/ipb49c2ehy0e8k9pdyean87k.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/f7vptiix8blamouj1tuudru9.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies